New Frontiers in ADC Analysis: Exploring Advances in Chromatography, Electrophoresis & Mass Spectrometry

  • Defining CQAs of antibody and bispecific Drug Substance intermediates and ADC Drug Substances and Drug Products
  • Exploring the role of cutting-edge analytical strategies based on the use of LC, CE, and MS, either as standalone techniques or in combination
  • Evaluating use of tailored analytical methods for comprehensive ADC characterisation and early developability assessment with relevant benchmarks